Polygenic risk scores across the extended psychosis spectrum.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
26 11 2021
Historique:
received: 27 08 2021
accepted: 29 10 2021
revised: 24 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 1 2 2022
Statut: epublish

Résumé

As early detection of symptoms in the subclinical to clinical psychosis spectrum may improve health outcomes, knowing the probabilistic susceptibility of developing a disorder could guide mitigation measures and clinical intervention. In this context, polygenic risk scores (PRSs) quantifying the additive effects of multiple common genetic variants hold the potential to predict complex diseases and index severity gradients. PRSs for schizophrenia (SZ) and bipolar disorder (BD) were computed using Bayesian regression and continuous shrinkage priors based on the latest SZ and BD genome-wide association studies (Psychiatric Genomics Consortium, third release). Eight well-phenotyped groups (n = 1580; 56% males) were assessed: control (n = 305), lower (n = 117) and higher (n = 113) schizotypy (both groups of healthy individuals), at-risk for psychosis (n = 120), BD type-I (n = 359), BD type-II (n = 96), schizoaffective disorder (n = 86), and SZ groups (n = 384). PRS differences were investigated for binary traits and the quantitative Positive and Negative Syndrome Scale. Both BD-PRS and SZ-PRS significantly differentiated controls from at-risk and clinical groups (Nagelkerke's pseudo-R

Identifiants

pubmed: 34836939
doi: 10.1038/s41398-021-01720-0
pii: 10.1038/s41398-021-01720-0
pmc: PMC8626446
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

600

Informations de copyright

© 2021. The Author(s).

Références

Schizophr Res. 2010 Nov;123(2-3):188-98
pubmed: 20692125
Psychol Med. 2009 Feb;39(2):179-95
pubmed: 18606047
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Biol Psychiatry. 2020 Aug 15;88(4):304-314
pubmed: 32430200
Nat Commun. 2019 Apr 16;10(1):1776
pubmed: 30992449
Curr Top Behav Neurosci. 2010;4:97-121
pubmed: 21312398
Br J Psychiatry. 2014 Aug;205(2):88-94
pubmed: 25252316
Psychol Med. 2022 Apr;52(6):1069-1079
pubmed: 32758327
Shanghai Arch Psychiatry. 2013 Feb;25(1):55-9
pubmed: 24948867
Mol Psychiatry. 2015 Feb;20(2):150-1
pubmed: 24888364
JAMA Psychiatry. 2020 Jul 1;77(7):755-765
pubmed: 32159746
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Lancet Psychiatry. 2017 Jan;4(1):57-62
pubmed: 27932233
Acta Psychiatr Scand. 2014 Oct;130(4):311-7
pubmed: 24961959
Schizophr Res. 2013 May;146(1-3):69-78
pubmed: 23473813
Mol Psychiatry. 2021 Jun;26(6):2457-2470
pubmed: 32203155
Acta Psychiatr Scand. 2012 Oct;126(4):266-73
pubmed: 22486536
Biol Psychiatry. 2017 Mar 15;81(6):470-477
pubmed: 27765268
Transl Psychiatry. 2019 Nov 14;9(1):300
pubmed: 31727878
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Am J Psychiatry. 2020 Feb 1;177(2):155-163
pubmed: 31711302
JAMA Psychiatry. 2016 Dec 01;73(12):1239-1248
pubmed: 27806157
Handb Exp Pharmacol. 2012;(212):187-212
pubmed: 23129333
Transl Psychiatry. 2018 Apr 12;8(1):78
pubmed: 29643358
JAMA Psychiatry. 2019 Jul 1;76(7):739-748
pubmed: 30969333
PLoS Genet. 2019 Apr 25;15(4):e1008060
pubmed: 31022172
Biol Psychiatry. 2021 Nov 1;90(9):611-620
pubmed: 34304866
Front Public Health. 2014 Oct 01;2:166
pubmed: 25325050
Psychol Med. 2017 May;47(7):1246-1258
pubmed: 28065182
Biol Psychiatry. 2007 Oct 1;62(7):784-92
pubmed: 17336946
Mol Psychiatry. 2020 Apr;25(4):844-853
pubmed: 30610197
Transl Psychiatry. 2017 Jan 10;7(1):e993
pubmed: 28072414
Genet Med. 2019 Aug;21(8):1705-1707
pubmed: 30635622
Nature. 2011 Jul 06;475(7354):27-30
pubmed: 21734685
Transl Psychiatry. 2018 Aug 31;8(1):174
pubmed: 30171181
J Ment Health Policy Econ. 2011 Dec;14(4):197-200
pubmed: 22345361
J Psychiatr Res. 2012 Jul;46(7):960-5
pubmed: 22551659
J Affect Disord. 2015 Sep 01;183:310-4
pubmed: 26047958
Eur Psychiatry. 2015 Mar;30(3):405-16
pubmed: 25735810
Schizophr Bull. 2015 May;41(3):736-43
pubmed: 25392519
JAMA Psychiatry. 2016 Mar;73(3):221-8
pubmed: 26818099
Schizophr Bull. 2018 Feb 15;44(2):338-347
pubmed: 29036523
Schizophr Bull. 2012 Mar;38(2):360-7
pubmed: 20709763
Dialogues Clin Neurosci. 2020 Mar;22(1):7-15
pubmed: 32699501
Br J Psychiatry. 2018 Sep;213(3):535-541
pubmed: 30113282
Philos Ethics Humanit Med. 2019 Feb 27;14(1):4
pubmed: 30813945
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Bull. 2015 Mar;41 Suppl 2:S436-43
pubmed: 25810058
Nat Genet. 2019 Apr;51(4):584-591
pubmed: 30926966
Lancet. 2009 Jan 17;373(9659):234-9
pubmed: 19150704
Mol Psychiatry. 2021 Jun;26(6):2493-2503
pubmed: 33462330
Front Psychiatry. 2019 Jul 11;10:476
pubmed: 31354543
Front Psychol. 2017 May 15;8:775
pubmed: 28555120
Schizophr Res. 2019 Jun;208:67-75
pubmed: 31076262
Front Psychiatry. 2013 Oct 14;4:136
pubmed: 24133464
Schizophr Bull. 2015 Mar;41 Suppl 2:S408-16
pubmed: 25810055
Transl Psychiatry. 2020 Sep 18;10(1):314
pubmed: 32948743
JAMA Psychiatry. 2013 Jan;70(1):107-20
pubmed: 23165428
Schizophr Bull. 2014 May;40(3):504-15
pubmed: 24567502
Schizophr Res. 2002 Sep 1;57(1):5-13
pubmed: 12165371
Schizophr Bull. 1991;17(4):555-64
pubmed: 1805349
Am J Psychiatry. 2020 Oct 1;177(10):936-943
pubmed: 32660297
Am J Med Genet B Neuropsychiatr Genet. 2019 Mar;180(2):89-102
pubmed: 30070057
Am J Psychiatry. 2019 Jan 1;176(1):21-28
pubmed: 30392411
J Affect Disord. 2005 Oct;88(2):217-33
pubmed: 16125784
Bipolar Disord. 2020 Mar;22(2):174-181
pubmed: 31628696
J Youth Adolesc. 2021 Jan;50(1):159-176
pubmed: 33230654
Schizophr Bull. 2020 Feb 26;46(2):336-344
pubmed: 31206164
Schizophr Bull. 2021 Aug 21;47(5):1495-1508
pubmed: 33876249
Nat Neurosci. 2016 Oct 26;19(11):1397-1407
pubmed: 27786179
J Psychiatr Res. 2018 Jan;96:209-217
pubmed: 29102815
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
NPJ Schizophr. 2016 Oct 12;2:16035
pubmed: 27738648
Psychol Med. 2018 Sep;48(12):1925-1936
pubmed: 29334044
J Hum Genet. 2021 Jan;66(1):53-60
pubmed: 32770057
PLoS One. 2014 Apr 09;9(4):e94398
pubmed: 24718684
Mol Psychiatry. 2015 Feb;20(1):72-6
pubmed: 25385368
Schizophr Bull. 2016 Nov;42(6):1395-1406
pubmed: 26980142
Mol Psychiatry. 2021 Jun;26(6):2553-2561
pubmed: 32127647
Hum Genet. 2021 Mar;140(3):441-455
pubmed: 32772156
Schizophr Bull. 2020 Jan 4;46(1):110-120
pubmed: 31219164
Am J Med Genet B Neuropsychiatr Genet. 2018 Jun;177(4):416-425
pubmed: 29603866
Schizophr Bull. 2014 Sep;40(5):1095-104
pubmed: 24243441
Transl Psychiatry. 2018 Sep 10;8(1):188
pubmed: 30201969
JAMA Psychiatry. 2016 Mar;73(3):193-4
pubmed: 26817666
Front Psychiatry. 2019 Apr 17;10:174
pubmed: 31057431
Harv Rev Psychiatry. 2016 Mar-Apr;24(2):87-103
pubmed: 26954594
Schizophr Res. 2017 Jun;184:116-121
pubmed: 27916287
Arch Gen Psychiatry. 2012 Mar;69(3):220-9
pubmed: 22393215
Schizophr Bull. 2015 Mar;41 Suppl 2:S396-407
pubmed: 25548386
Nat Methods. 2013 Jan;10(1):5-6
pubmed: 23269371
Nat Genet. 2021 Jun;53(6):817-829
pubmed: 34002096
PLoS One. 2012;7(6):e37852
pubmed: 22761660
World Psychiatry. 2018 Feb;17(1):49-66
pubmed: 29352556
Nat Rev Genet. 2018 Sep;19(9):581-590
pubmed: 29789686
Int J Psychophysiol. 2015 Aug;97(2):131-8
pubmed: 26027781

Auteurs

Lukasz Smigielski (L)

Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland. lukasz.smigielski@uzh.ch.
The Zurich Program for Sustainable Development of Mental Health Services (ZInEP), Psychiatric University Hospital Zurich, Zurich, Switzerland. lukasz.smigielski@uzh.ch.

Sergi Papiol (S)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Anastasia Theodoridou (A)

The Zurich Program for Sustainable Development of Mental Health Services (ZInEP), Psychiatric University Hospital Zurich, Zurich, Switzerland.
Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Karsten Heekeren (K)

The Zurich Program for Sustainable Development of Mental Health Services (ZInEP), Psychiatric University Hospital Zurich, Zurich, Switzerland.
Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Department of Psychiatry and Psychotherapy I, LVR-Hospital, Cologne, Germany.

Miriam Gerstenberg (M)

Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
The Zurich Program for Sustainable Development of Mental Health Services (ZInEP), Psychiatric University Hospital Zurich, Zurich, Switzerland.

Diana Wotruba (D)

The Zurich Program for Sustainable Development of Mental Health Services (ZInEP), Psychiatric University Hospital Zurich, Zurich, Switzerland.

Roman Buechler (R)

The Zurich Program for Sustainable Development of Mental Health Services (ZInEP), Psychiatric University Hospital Zurich, Zurich, Switzerland.
Department of Neuroradiology, University Hospital Zurich, Zurich, Switzerland.

Per Hoffmann (P)

Department of Biomedicine, Human Genomics Research Group, University Hospital and University of Basel, Basel, Switzerland.
Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.

Stefan Herms (S)

Department of Biomedicine, Human Genomics Research Group, University Hospital and University of Basel, Basel, Switzerland.
Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.

Kristina Adorjan (K)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Heike Anderson-Schmidt (H)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.

Monika Budde (M)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.

Ashley L Comes (AL)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
International Max Planck Research School for Translational Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.

Katrin Gade (K)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.

Maria Heilbronner (M)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.

Urs Heilbronner (U)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.

Janos L Kalman (JL)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
International Max Planck Research School for Translational Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.

Farahnaz Klöhn-Saghatolislam (F)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.

Daniela Reich-Erkelenz (D)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Sabrina K Schaupp (SK)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.

Eva C Schulte (EC)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Fanny Senner (F)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Ion-George Anghelescu (IG)

Department of Psychiatry and Psychotherapy, Mental Health Institute, Berlin, Germany.

Volker Arolt (V)

Institute for Translational Psychiatry, University of Münster, Münster, Germany.

Bernhard T Baune (BT)

Department of Psychiatry, University of Münster, Münster, Germany.
Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia.
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.

Udo Dannlowski (U)

Institute for Translational Psychiatry, University of Münster, Münster, Germany.

Detlef E Dietrich (DE)

AMEOS Clinical Center Hildesheim, Hildesheim, Germany.
Center for Systems Neuroscience (ZSN), Hannover, Germany.

Andreas J Fallgatter (AJ)

Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health (TüCMH), University of Tübingen, Tübingen, Germany.

Christian Figge (C)

Karl-Jaspers Clinic, European Medical School Oldenburg-Groningen, Oldenburg, Germany.

Markus Jäger (M)

Department of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, Günzburg, Germany.

Georg Juckel (G)

Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany.

Carsten Konrad (C)

Department of Psychiatry and Psychotherapy, Agaplesion Diakonieklinikum, Rotenburg, Germany.

Vanessa Nieratschker (V)

Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health (TüCMH), University of Tübingen, Tübingen, Germany.

Jens Reimer (J)

Department of Psychiatry, Klinikum Bremen-Ost, Bremen, Germany.
Department of Psychiatry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Eva Reininghaus (E)

Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for Bipolar Affective Disorder, Medical University of Graz, Graz, Austria.

Max Schmauß (M)

Clinic for Psychiatry, Psychotherapy and Psychosomatics, Augsburg University, Medical Faculty, Bezirkskrankenhaus Augsburg, Augsburg, Germany.

Carsten Spitzer (C)

Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Rostock, Rostock, Germany.

Martin von Hagen (M)

Clinic for Psychiatry and Psychotherapy, Clinical Center Werra-Meißner, Eschwege, Germany.

Jens Wiltfang (J)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
iBiMED, Medical Sciences Department, University of Aveiro, Aveiro, Portugal.

Jörg Zimmermann (J)

Psychiatrieverbund Oldenburger Land gGmbH, Karl-Jaspers-Klinik, Bad Zwischenahn, Germany.

Anna Gryaznova (A)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.

Laura Flatau-Nagel (L)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.

Markus Reitt (M)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.

Milena Meyers (M)

Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany.

Barbara Emons (B)

Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany.

Ida Sybille Haußleiter (IS)

Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany.

Fabian U Lang (FU)

Department of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, Günzburg, Germany.

Thomas Becker (T)

Department of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, Günzburg, Germany.

Moritz E Wigand (ME)

Department of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, Günzburg, Germany.

Stephanie H Witt (SH)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Franziska Degenhardt (F)

Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.

Andreas J Forstner (AJ)

Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
Centre for Human Genetics, University of Marburg, Marburg, Germany.
Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, Germany.

Marcella Rietschel (M)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Markus M Nöthen (MM)

Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.

Till F M Andlauer (TFM)

Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Wulf Rössler (W)

The Zurich Program for Sustainable Development of Mental Health Services (ZInEP), Psychiatric University Hospital Zurich, Zurich, Switzerland.
Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin, Berlin, Germany.
Laboratory of Neuroscience (LIM 27), Institute of Psychiatry, Universidade de São Paulo, São Paulo, Brazil.

Susanne Walitza (S)

Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.

Peter Falkai (P)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Thomas G Schulze (TG)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, USA.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Edna Grünblatt (E)

Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH